Patent Grant
7999128
The present invention relates to hydroxybenzophenone UV absorbers, to the preparation of these compounds, to the use of these compounds for protecting human and animal skin and hair from the harmful effects of UV radiation, and to their use in cosmetic and pharmaceutical formulations.
It is known that certain organic UV filters, such as, for example, poorly soluble benzophenone derivatives, have pronounced UV filter properties. However, the solubility of such organic UV filters in solvents like Cyclomethicone (cyclopentasiloxane) that are suitable for specific cosmetic formulations like sprays wherein the active is dissolved in Cyclomethicone and silicon oils is often inadequate.
There is a strong interest in organic light-protective filters that can be readily incorporated in cosmetic formulations that is to say that have good oil-solubility.
The problem of the present invention is therefore to find organic UV filters or mixtures of UV filters that have good solubility in solvents that are suitable for cosmetic formulations.
It has now been surprisingly found that UV absorber compositions comprising selected silylated benzophenone derivatives have such properties.
The present invention therefore refers to hydroxyphenylbenzophenone derivatives of formula,
wherein
C1-C20alkyl denotes a linear or branched, unsubstituted or substituted alkyl group such as, for example, methyl, ethyl, propyl, isopropyl, n-butyl, n-hexyl, cyclohexyl, n-decyl, n-dodecyl, n-octadecyl, eicosyl, methoxyethyl, ethoxypropyl, 2-ethylhexyl, hydroxyethyl, chloropropyl, N,N-diethylaminopropyl, cyanoethyl, phenethyl, benzyl, p-tert-butylphenethyl, p-tert-octylphenoxyethyl, 3-(2,4-di-tert-amylphenoxy)-propyl, ethoxycarbonylmethyl-2-(2-hydroxyethoxy)ethyl or 2-furylethyl.
C2-C20alkenyl is for example allyl, methallyl, isopropenyl, 2-butenyl, 3-butenyl, isobutenyl, n-penta-2,4-dienyl, 3-methyl-but-2-enyl, n-oct-2-enyl, n-dodec-2-enyl, iso-dodecenyl, n-dodec-2-enyl or n-octadec-4-enyl.
C3-C10cycloalkyl is for example cyclopropyl, cyclobutyl, cyclopentyl, cycloheptyl, cyclooctyl, cyclononyl or cyclodecyl and preferably cyclohexyl. These radicals may be substituted, for example by one or more or equal or different C1-C4alkyl radicals, preferably by methyl, and/or hydroxy. If cycloalkyl radicals are substituted by one or more radicals, they are preferably substituted by one, two or four, preferably by one or two equal or radicals.
C3-C10cycloalkenyl is for example cyclopropenyl, cyclobutenyl, cyclopentenyl, cycloheptenyl, cycloocentyl, cyclononenyl or cyclodecenyl and preferably cyclohexenyl. These radicals may be substituted with one or more equal or different C1-C4alkyl radical, preferably with methyl, and/or hydroxy. If cycloalkenyl radicals are substituted with one or more radicals they are preferably substituted with one, two, three or four, preferably with one or two equal or different radicals.
Hydroxy substituted C1-C5alkyl groups are for example hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl or hydroxypentyl.
C1-C6alkylene is for example methylene, ethylene, propylene, butylenes or hexylene.
The alklyene radicals may optionally be substituted by one or more C1-C5alkyl radicals.
If R1 and R2 are heterocyclic radicals, these comprise one, two, three or four equal or different ring hetero atoms. Special preference is given to heterocycles which contain one, two or three, especially one or two, identical or different hetero atoms. The heterocycles may be mono- or poly-cyclic, for example mono-, bi- or tri-cyclic. They are preferably mono- or bi-cyclic, especially monocyclic. The rings preferably contain 5, 6 or 7 ring members. Examples of monocyclic and bicyclic heterocyclic systems from which radicals occurring in the compounds of formula (1) may be derived are, for example, pyrrole, furan, thiophene, imidazole, pyrazole, 1,2,3-triazole, 1,2,4-triazole, pyridine, pyridazine, pyrimidine, pyrazine, pyran, thiopyran, 1,4-dioxane, 1,2-oxazine, 1,3-oxazine, 1,4-oxazine, indole, benzothiophene, benzofuran, pyrrolidine, piperidine, piperazine, morpholine and thiomorpholine.
In the compounds of formula (1) R1 and R2 are preferably C1-C20alkyl, more preferably C1-C5alkyl and most preferably R1 and R2 in formula (1) have the same definition
In the compounds of formula (1) A is preferably C3-C6alkylene; or (C1-C5alkylene)-O—(CO)—(C1-C5)alkylene.
In formula (1) m is preferably 0.
R3 and R4 in formula (1) are preferably a radical of formula
wherein
R6 is C1-C6alkyl.
Most preferred are compounds of formula (1), wherein
R1 and R2 are C1-C5alkyl;
R3 and R4 are a radical of formula
R6 is C1-C5alkyl;
A is C3alkylene; and
m is 0.
The compounds of formula (1) may be prepared by a manner known per se.
Usually they are prepared by reacting a siloxanol compound of formula
with a benzophenone carboxylic acid or anhydride of the formula
according to the following reaction scheme:
R1 and R2, R3, R4 and R5, A and m are defined as in formula (1).
Another preparation route comprises hydrosilylation of the unsaturated ester of benzophenone carboxylic acid e.g. Allylesters using known Catalyst (Pt, Cu) and corresponding hydrosiloxane.
The reaction is usually carried out at a temperature from 25 to 200° C. Generally a solvent is not necessary for this reaction. If a solvent is used however, preferably the solvents as used in the working examples are preferred.
The reaction time is usually from 0.5 to 20 h.
The starting compounds of formula
are known from the prior art, for example WO 2004/052837.
They are prepared by a manner known per se by dehydratisation of the compound of formula
to the compound of formula (1c)
R1 and R2 are defined as in formula (1).
The compounds of the formula (1) according to the present invention are particularly suitable as UV filters, i.e. for protecting ultraviolet-sensitive organic materials, in particular the skin and hair of humans and animals, from the harmful effects of UV radiation. These compounds are therefore suitable as sunscreens in cosmetic, pharmaceutical and veterinary medical preparations. These compounds are preferably used in dissolved form.
The cosmetic formulations or pharmaceutical compositions according to the present invention may additionally contain one or more than one further conventional UV filter.
The cosmetic or pharmaceutical preparations may be, for example, creams, gels, lotions, alcoholic and aqueous/alcoholic solutions, emulsions, wax/fat compositions, stick preparations, powders or ointments. In addition to the above-mentioned UV filters, the cosmetic or pharmaceutical preparations may contain further adjuvants as described below.
As water- and oil-containing emulsions (e.g. W/O, O/W, O/W/O and W/O/W emulsions or microemulsions) the preparations contain, for example, from 0.1 to 30% by weight, preferably from 0.1 to 15% by weight and especially from 0.5 to 10% by weight, based on the total weight of the composition, of one or more UV absorbers, from 1 to 60% by weight, especially from 5 to 50% by weight and preferably from 10 to 35% by weight, based on the total weight of the composition, of at least one oil component, from 0 to 30% by weight, especially from 1 to 30% by weight and preferably from 4 to 20% by weight, based on the total weight of the composition, of at least one emulsifier, from 10 to 90% by weight, especially from 30 to 90% by weight, based on the total weight of the composition, of water, and from 0 to 88.9% by weight, especially from 1 to 50% by weight, of further cosmetically acceptable adjuvants.
The cosmetic or pharmaceutical compositions/preparations according to the invention may also contain one or one more additional compounds like fatty alcohols, esters of fatty acids, natural or synthetic triglycerides including glyceryl esters and derivatives, pearlescent waxes, hydrocarbon oils, silicones or siloxanes, organosubstituted super-fatting agents, surfactant consistency regulators/thickeners and rheology modifiers, polymers, biogenic active ingredients, deodorising active ingredients, anti-dandruff agents, antioxidants, hydrotropic agents, preservatives and bacteria-inhibiting agents, perfume oils, colourants, polymeric beads or hollow spheres as spf enhancers.
Cosmetic or Pharmaceutical Preparations
Cosmetic or pharmaceutical formulations are ingredients in a wide variety of cosmetic preparations. The following preparations are of special interest:
The final formulations listed may exist in a wide variety of presentation forms, for example:
Of special importance as cosmetic preparations for the skin are light-protective preparations, such as sun milks, lotions, creams, oils, sunblocks or tropicals, pretanning preparations or after-sun preparations, also skin-tanning preparations, for example self-tanning creams. Of particular interest are sun protection creams, sun protection lotions, sun protection milk and sun protection preparations in the form of a spray.
Of special importance as cosmetic preparations for the hair are the above-mentioned preparations for hair treatment, especially hair-washing preparations in the form of shampoos, hair conditioners, hair-care preparations, e.g. pretreatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair-straightening preparations, liquid hair-setting preparations, hair foams and hairsprays. Of special interest are hair-washing preparations in the form of shampoos.
A shampoo has, for example, the following composition: from 0.01 to 5% by weight of a UV absorber according to the invention, 12.0% by weight of sodium laureth-2-sulfate, 4.0% by weight of cocamidopropyl betaine, 3.0% by weight of sodium chloride, and water ad 100%.
Other typical ingredients in such formulations are preservatives, bactericides and bacteriostatic agents, perfumes, dyes, pigments, thickening agents, moisturizing agents, humectants, fats, oils, waxes or other typical ingredients of cosmetic and personal care formulations such as alcohols, poly-alcohols, polymers, electrolytes, organic solvents, silicon derivatives, emollients, emulsifiers or emulsifying surfactants, surfactants, dispersing agents, antioxidants, anti-irritants and anti-inflammatory agents etc.
The cosmetic preparation according to the invention is distinguished by excellent protection of human skin against the damaging effect of sunlight.
dissolved in 70 ml toluene are stirred during 7 h at 75-85° C. in an oil bath.
The reaction mass is worked off after evaporation with column chromatography (silicagel 60/toluene: acedic acid ethyl ester).
8 g of a pure product (bright-yellow oil) is obtained.
Eemental analysis: C=67.2%, H=7.9%, N=3.2% (Th: C=67.4%, H=7.8%, N=3.3%) λmax=350 nm; E 1/1=822.
The obtained compound is soluble in Cyclomethicone (solubility in Cyclomethicone is 1.8% at RT).
About 8 g of a pure endproduct of a yellow viscous oil (by determination via column chromatography) are obtained.
Elemental analysis: C, H, N in accordance with the theory.
λmax=350 nm; E 1/1=571
The solubility in Cyclomethicone at RT is >20%.
26 g of the compound of formula
and 58.8 g of the compound of formula (101a) are mixed together with 200 ml propyl acetate.
0.4 g 4-(dimethylamino)-pyridine and 1 g hydrochinone monomethylether are added and heated up to 95° C. within 3 h.
The mixture is concentrated to a volume of about 100 ml with the rotating evaporator and 600 ml methanol are added.
Colorless crystals of the compound of formula
are formed overnight.
12.8 g of the compound of formula (103a) are added to 50 ml 1-butanol and heated up to about 80° C. (under inert gas).
9.0 g of the compound of formula
and 5 drops of a Karstedt-catalysator (Aldrich) are dissolved in 10 ml 1-butanol and added dropwise within 30 min.
The solution is stirred at 80° C. for 8 h.
After concentration the raw product is purified via column chromatography to obtain the compound of formula (103).
λmax=357 nm; E 1/1=606
Six formulations of water silicone type are prepared. All formulation show high efficacy and an outstandingly smooth skin feel.
Examples B1 to B3 are water silicone formulations wherein the compound of formula (102) is used as silicone soluble UV-A filter.
Examples B4 to B6 are water silicone formulations wherein the compound of formula (103) is used as silicone soluble UV-A filter.
High SPF values and high UVA protection are obtained as shown in Table B1.
| Number | Date | Country | Kind |
|---|---|---|---|
| 06101454 | Feb 2006 | EP | regional |
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/EP2007/051117 | 2/6/2007 | WO | 00 | 11/20/2008 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2007/090832 | 8/16/2007 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 2938047 | Black | May 1960 | A |
| 4042613 | Takamizawa et al. | Aug 1977 | A |
| 4495360 | Anthony | Jan 1985 | A |
| 5270426 | Sakuta et al. | Dec 1993 | A |
| 5756793 | Valet et al. | May 1998 | A |
| 6071052 | Kerr | Jun 2000 | A |
| 6409995 | Habeck et al. | Jun 2002 | B1 |
| 7388102 | Berg-Schultz et al. | Jun 2008 | B2 |
| 20020001570 | Heidenfelder et al. | Jan 2002 | A1 |
| 20030152598 | Heidenfelder et al. | Aug 2003 | A1 |
| 20050008587 | Schulz et al. | Jan 2005 | A1 |
| 20050255066 | Berg-Schultz et al. | Nov 2005 | A1 |
| 20060018846 | Haase et al. | Jan 2006 | A1 |
| Number | Date | Country |
|---|---|---|
| 10011317 | Sep 2001 | DE |
| 9310745 | Jun 1993 | WO |
| 2006128614 | Dec 2006 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20090220439 A1 | Sep 2009 | US |
